Equity offering stocks in Korea: why they moved

1 article(s) on Korean Equity offering stocks, checked against filings and numbers.

U.S.Oct. 20, 2026

Disc Medicine up 39% on Phase 3 win, then a $350M offering is reported

On Oct. 19, Disc Medicine (+38.9%), Cleveland-Cliffs (+16.3%) and Veradermics (+12.4%) rose on filing-backed news. Disc Medicine drew a reported $350M offering after the close.